BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21242521)

  • 21. Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells.
    Wolthers KC; Otto SA; Lens SM; Kolbach DN; van Lier RA; Miedema F; Meyaard L
    Eur J Immunol; 1996 Aug; 26(8):1700-6. PubMed ID: 8765009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells.
    Groh ME; Maitra B; Szekely E; Koç ON
    Exp Hematol; 2005 Aug; 33(8):928-34. PubMed ID: 16038786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus.
    Sáez-Borderías A; Gumá M; Angulo A; Bellosillo B; Pende D; López-Botet M
    Eur J Immunol; 2006 Dec; 36(12):3198-206. PubMed ID: 17109473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.
    Rodolfo M; Zilocchi C; Accornero P; Cappetti B; Arioli I; Colombo MP
    J Immunol; 1999 Aug; 163(4):1923-8. PubMed ID: 10438927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane potential of CD4+ T cells is a subset specific feature that depends on the direct cell-to-cell contacts with monocytes.
    Marek N; Myśliwska J; Raczyńska K; Trzonkowski P
    Hum Immunol; 2010 Jul; 71(7):666-75. PubMed ID: 20457202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligation of TAPA-1 (CD81) or major histocompatibility complex class II in co-cultures of human B and T lymphocytes enhances interleukin-4 synthesis by antigen-specific CD4+ T cells.
    Secrist H; Levy S; DeKruyff RH; Umetsu DT
    Eur J Immunol; 1996 Jul; 26(7):1435-42. PubMed ID: 8766544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visualizing how T cells collect activation signals in vivo.
    Moreau HD; Bousso P
    Curr Opin Immunol; 2014 Feb; 26():56-62. PubMed ID: 24556401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release and intercellular transfer of cell surface CD81 via microparticles.
    Fritzsching B; Schwer B; Kartenbeck J; Pedal A; Horejsi V; Ott M
    J Immunol; 2002 Nov; 169(10):5531-7. PubMed ID: 12421929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocytes and Trogocytosis-Mediated Signaling.
    Reed J; Reichelt M; Wetzel SA
    Cells; 2021 Jun; 10(6):. PubMed ID: 34204661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms and functions for the duration of intercellular contacts made by lymphocytes.
    Davis DM
    Nat Rev Immunol; 2009 Aug; 9(8):543-55. PubMed ID: 19609264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trogocytic intercellular membrane exchanges among hematological tumors.
    LeMaoult J; Caumartin J; Daouya M; Switala M; Rebmann V; Arnulf B; Carosella ED
    J Hematol Oncol; 2015 Mar; 8():24. PubMed ID: 25887663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferential transfer of certain plasma membrane proteins onto T and B cells by trogocytosis.
    Daubeuf S; Aucher A; Bordier C; Salles A; Serre L; Gaibelet G; Faye JC; Favre G; Joly E; Hudrisier D
    PLoS One; 2010 Jan; 5(1):e8716. PubMed ID: 20090930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Face off--the interplay between activating and inhibitory immune receptors.
    Lanier LL
    Curr Opin Immunol; 2001 Jun; 13(3):326-31. PubMed ID: 11406364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity.
    Li KJ; Wu CH; Lu CH; Shen CY; Kuo YM; Tsai CY; Hsieh SC; Yu CL
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CD300 molecules: an emerging family of regulators of the immune system.
    Borrego F
    Blood; 2013 Mar; 121(11):1951-60. PubMed ID: 23293083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of immune reactivity by intercellular transfer.
    Dhainaut M; Moser M
    Front Immunol; 2014; 5():112. PubMed ID: 24734030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer.
    Zeller T; Münnich IA; Windisch R; Hilger P; Schewe DM; Humpe A; Kellner C
    Front Immunol; 2023; 14():1240275. PubMed ID: 37781391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation and regulation of alloreactive T cell immunity in solid organ transplantation.
    Duneton C; Winterberg PD; Ford ML
    Nat Rev Nephrol; 2022 Oct; 18(10):663-676. PubMed ID: 35902775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NK Cells Acquire CCR5 and CXCR4 by Trogocytosis in People Living with HIV-1.
    Vo DN; Leventoux N; Campos-Mora M; Gimenez S; Corbeau P; Villalba M
    Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies.
    Morandi F; Airoldi I
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.